Market Cap to Net Assets Ratio: Senseonics Holdings (SENS)

Senseonics Holdings - graphic logo of issuer SENS

The market trend for Senseonics Holdings (SENS), a developer of glucose monitoring systems, is based on a stable engineering staff and a partner distribution model, with the metric standing at 5.72. However, the battle for market share requires massive expenditures, which nullifies free cash flow. The situation is further complicated by logistics disruptions and sanction barriers, which significantly slow the rollout of products into foreign markets.

Senseonics Holdings Inc (SENS) - Market Value to Book Value from 07/04/2022 to 10/30/2026
Manufactured product of senseonics.com

The scaling dynamics of Senseonics Holdings (SENS) within the glucose monitoring sector are reflected in the shifting ratio of market capitalization to balance sheet, which compares the current share price to net assets. This coefficient measures the market premium over equity, demonstrating investor confidence in R&D efficiency and management's ability to convert technological superiority into market share amid rising operating expenses.

Competing companies

DexCom, Inc. (DXCM) - Market Value to Book Value Ratio|PEN - Market Capitalization to Book Value|Market Cap to Net Assets Ratio NOVT|HAE (Haemonetics Corp) - Market Cap to Book Value Multiple|Market Capitalization to Book Value Ratio INSP|PRCT (Procept) - Market Value to Book Value|Market Capitalization to Book Value Ratio CNMD (CONMED Corporation)|pulsebiosciences.com (PLSE) - Market-to-Book Ratio|INMD - Market Value to Book Value Ratio|Market Value to Book Value PMI (Picard Medical Corp)|SRDX: Market Capitalization to Book Value Ratio|NeuroPace Medical (NPCE) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Tactile Systems Technology, Inc.|sanuwave.com - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio OM|ELMD - Market-to-Book Ratio|LENSAR, Inc - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio AVITA Medical Inc RCEL|PROF: Market Cap to Net Assets Ratio|Baird Medical Investment - Market Cap to Book Value Multiple|EDAP: Market Capitalization to Book Value Ratio|APYX - Market Capitalization to Book Value|ICCM (IceCure Medical Ltd.) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Pulmonx Corp. (LUNG)|Market Cap to Net Assets Ratio TELA (TELA Bio, Inc.)|CTSO (cytosorbents.com) - Market Value to Book Value|Market Value to Book Value Ratio Sensus Healthcare SRTS|ZYXI - Market Cap to Net Assets Ratio|electroCore Medical - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Vicarious Surgical Inc.|IINN: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio ICU|IRIX (IRIDEX Corp) - Market Capitalization to Book Value Ratio|Intelligent Bio (INBS) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio XAIR|Market Cap to Net Assets Ratio Profusa, Inc PFSA|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|Market Capitalization to Book Value Ratio GlucoTrack Inc. GCTK|NAOV - Market Value to Book Value Ratio|VERO: Market Value to Book Value Ratio|NUWE (CHF Solutions) - Market Cap to Net Assets Ratio|Aethlon Medical Corp - Market Value to Book Value|ASXC (Asensus Surgical Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio avinger.com AVGR|Market Value to Book Value Ratio biosig.com (BSGM)|Cutera Inc. (CUTR) - Market Value to Equity Ratio|Know Labs Corp - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Nevro Corp. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value ReShape Lifesciences RSLS|Silk Road Medical (SILK) - Market Value to Book Value Ratio